daunorubicin has been researched along with Liver Dysfunction in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barber, L; Clay, J; Devlia, V; Feliu, J; Mufti, G; Pagliuca, A; Raj, K; Shaw, B | 1 |
| Choi, MK; Chung, SJ; Kim, DD; Shim, CK; Song, IS | 1 |
| D'Cruz, CA; Harcke, HT; Huff, DS; Naiman, JL; Wimmer, RS | 1 |
| Celiński, K; Chibowska, I; Chibowski, D; Pokora, J | 1 |
| Akiba, J; Fuyama, S; Hayashi, T; Kosugi, S; Maeda, K; Sasaki, H; Satoh, S; Suzuki, K; Tajima, K; Yahagi, A | 1 |
| Barbera, V; Gambino, R; Mariani, G; Minardi, V; Quintini, G; Spadola, V | 1 |
| Ardalan, B; Bier, C; Herman, E; Krop, S; Waravdekar, V | 1 |
| Bodey, GP; Burgess, M; Feun, LG; Kavanagh, J; Loo, TL; Lu, K; Savaraj, N | 1 |
8 other study(ies) available for daunorubicin and Liver Dysfunction
| Article | Year |
|---|---|
Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cytarabine; Daunorubicin; Drug Therapy, Combination; Egg Hypersensitivity; Etoposide; Female; Food Hypersensitivity; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Immunosuppressive Agents; Intestinal Diseases; Leukemia, Myeloid, Acute; Liver Diseases; Male; Middle Aged; Nut Hypersensitivity; Seafood; Tacrolimus; Transplantation Conditioning; Vidarabine | 2014 |
Altered pharmacokinetics of daunorubicin in rats with CCl4-induced hepatic injury.
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Daunorubicin; Liver Diseases; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley | 2007 |
Veno-occlusive disease of the liver in children following chemotherapy for acute myelocytic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Budd-Chiari Syndrome; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Daunorubicin; Drug Therapy, Combination; Female; Hepatic Veins; Humans; Leukemia, Myeloid, Acute; Liver Diseases; Male; Radionuclide Imaging; Thioguanine | 1983 |
Morphological and biochemical studies of daunorubicin hepatotoxicity including the protective effects of tocopherol and ascorbic acid.
Topics: Acid Phosphatase; Alanine Transaminase; Animals; Antibiotics, Antineoplastic; Ascorbic Acid; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Confidence Intervals; Daunorubicin; Liver Diseases; Male; Rats; Rats, Wistar; Vitamin E | 1995 |
Multiple inflammatory pseudotumors of the liver associated with acute myeloblastic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cytarabine; Daunorubicin; Diagnosis, Differential; Granuloma, Plasma Cell; Humans; Leukemia, Myeloid, Acute; Liver Abscess; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Mercaptopurine; Prednisolone; Tomography, X-Ray Computed | 1998 |
Successful treatment of hepatosplenic candidiasis in an elderly patient with acute myeloid leukemia using liposomal daunorubicin and fluconazole.
Topics: Antibiotics, Antineoplastic; Antifungal Agents; Antineoplastic Agents; Candidiasis; Daunorubicin; Disease-Free Survival; Fluconazole; Humans; Kidney Diseases; Leukemia, Myelomonocytic, Acute; Liposomes; Liver Diseases; Male; Middle Aged; Treatment Outcome | 2001 |
Reduction of daunorubicin lethality and myocardial cellular alterations by pretreatment with ICRF-187 in Syrian golden hamsters.
Topics: Animals; Body Weight; Chemical and Drug Induced Liver Injury; Cricetinae; Daunorubicin; Heart Diseases; Liver; Liver Diseases; Male; Mesocricetus; Myocardium; Piperazines; Rats; Razoxane; Stereoisomerism; Time Factors | 1979 |
Clinical pharmacology of 4-demethoxydaunorubicin (DMDR).
Topics: Daunorubicin; Drug Evaluation; Humans; Idarubicin; Leukopenia; Liver Diseases; Metabolic Clearance Rate | 1986 |